Literature DB >> 29327327

Identifying potentially common genes between dyslipidemia and osteoporosis using novel analytical approaches.

Xu Lin1, Cheng Peng2, Jonathan Greenbaum3, Zhang-Fang Li4, Ke-Hao Wu3, Zeng-Xin Ao1, Tong Zhang4, Jie Shen4, Hong-Wen Deng5,6.   

Abstract

Dyslipidemia (DL) is closely related to osteoporosis (OP), while the exact common genetic mechanisms are still largely unknown. We proposed to use novel genetic analysis methods with pleiotropic information to identify potentially novel and/or common genes for the potential shared pathogenesis associated with OP and/or DL. We assessed the pleiotropy between plasma lipid (PL) and femoral neck bone mineral density (FNK BMD). We jointly applied the conditional false discovery rate (cFDR) method and the genetic analysis incorporating pleiotropy and annotation (GPA) method to the summary statistics provided by genome-wide association studies (GWASs) of FNK BMD (n = 49,988) and PL (n = 188,577) to identify potentially novel and/or common genes for BMD/PL. We found strong pleiotropic enrichment between PL and FNK BMD. Two hundred and forty-five PL SNPs were identified as potentially novel SNPs by cFDR and GPA. The corresponding genes were enriched in gene ontology (GO) terms "phospholipid homeostasis" and "chylomicron remnant clearance". Three SNPs (rs2178950, rs9939318, and rs9368716) might be the pleiotropic ones and the corresponding genes NLRC5 (rs2178950) and TRPS1 (rs9939318) were involved in NF-κB signaling pathway and Wnt signaling pathway as well as inflammation and innate immune processes. Our study validated the pleiotropy between PL and FNK BMD, and corroborated the reliability and high-efficiency of cFDR and GPA methods in further analyses of existing GWASs with summary statistics. We identified potentially common and/or novel genes for PL and/or FNK BMD, which may provide new insight and direction for further research.

Entities:  

Keywords:  Dyslipidemia; GPA; Osteoporosis; Pleiotropy; cFDR

Mesh:

Substances:

Year:  2018        PMID: 29327327      PMCID: PMC5949092          DOI: 10.1007/s00438-017-1414-1

Source DB:  PubMed          Journal:  Mol Genet Genomics        ISSN: 1617-4623            Impact factor:   3.291


  50 in total

1.  Controlling the false discovery rate in behavior genetics research.

Authors:  Y Benjamini; D Drai; G Elmer; N Kafkafi; I Golani
Journal:  Behav Brain Res       Date:  2001-11-01       Impact factor: 3.332

Review 2.  Genetics of osteoporosis from genome-wide association studies: advances and challenges.

Authors:  J Brent Richards; Hou-Feng Zheng; Tim D Spector
Journal:  Nat Rev Genet       Date:  2012-07-18       Impact factor: 53.242

Review 3.  The IkappaB kinase complex: master regulator of NF-kappaB signaling.

Authors:  Laura A Solt; Michael J May
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

4.  Relationship between vitamin D receptor gene polymorphisms, cardiovascular risk factors and adiponectin in a healthy young population.

Authors:  Aline Hajj; Rima Chedid; Eliane Chouery; André Megarbané; Marie-Hélène Gannagé-Yared
Journal:  Pharmacogenomics       Date:  2016-09-27       Impact factor: 2.533

Review 5.  Update on statins: hope for osteoporotic fracture healing treatment.

Authors:  Nurul 'Izzah Ibrahim; Norazlina Mohamed; Ahmad Nazrun Shuid
Journal:  Curr Drug Targets       Date:  2013-12       Impact factor: 3.465

6.  Riplet/RNF135, a RING finger protein, ubiquitinates RIG-I to promote interferon-beta induction during the early phase of viral infection.

Authors:  Hiroyuki Oshiumi; Misako Matsumoto; Shigetsugu Hatakeyama; Tsukasa Seya
Journal:  J Biol Chem       Date:  2008-11-18       Impact factor: 5.157

Review 7.  Osteoporosis in china.

Authors:  Y Wang; Y Tao; M E Hyman; J Li; Y Chen
Journal:  Osteoporos Int       Date:  2009-05-05       Impact factor: 4.507

8.  Relationship between serum total cholesterol level and serum biochemical bone turnover markers in healthy pre- and postmenopausal women.

Authors:  Tae-Dong Jeong; Woochang Lee; Sung-Eun Choi; Jae Seung Kim; Hong-Kyu Kim; Sung Jin Bae; Sail Chun; Won-Ki Min
Journal:  Biomed Res Int       Date:  2014-05-15       Impact factor: 3.411

Review 9.  The Relationship between Metabolic Syndrome and Osteoporosis: A Review.

Authors:  Sok Kuan Wong; Kok-Yong Chin; Farihah Hj Suhaimi; Fairus Ahmad; Soelaiman Ima-Nirwana
Journal:  Nutrients       Date:  2016-06-07       Impact factor: 5.717

Review 10.  Overview of guidelines for the management of dyslipidemia: EU perspectives.

Authors:  Vicente Giner-Galvañ; María José Esteban-Giner; Vicente Pallarés-Carratalá
Journal:  Vasc Health Risk Manag       Date:  2016-09-06
View more
  4 in total

1.  Identification of novel functional CpG-SNPs associated with type 2 diabetes and coronary artery disease.

Authors:  Zun Wang; Chuan Qiu; Xu Lin; Lan-Juan Zhao; Yong Liu; Xinrui Wu; Qian Wang; Wei Liu; Kelvin Li; Hong-Wen Deng; Si-Yuan Tang; Hui Shen
Journal:  Mol Genet Genomics       Date:  2020-03-11       Impact factor: 3.291

2.  The analysis of causal relationships between blood lipid levels and BMD.

Authors:  Stacey S Cherny; Maxim B Freidin; Frances M K Williams; Gregory Livshits
Journal:  PLoS One       Date:  2019-02-22       Impact factor: 3.240

3.  Identification of novel SNPs associated with coronary artery disease and birth weight using a pleiotropic cFDR method.

Authors:  Xinrui Wu; Xu Lin; Qi Li; Zun Wang; Na Zhang; Mengyuan Tian; Xiaolei Wang; Hongwen Deng; Hongzhuan Tan
Journal:  Aging (Albany NY)       Date:  2020-12-19       Impact factor: 5.682

Review 4.  Twelve years of GWAS discoveries for osteoporosis and related traits: advances, challenges and applications.

Authors:  Xiaowei Zhu; Weiyang Bai; Houfeng Zheng
Journal:  Bone Res       Date:  2021-04-29       Impact factor: 13.567

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.